Abstract
The result of the Preventive Angioplasty in Acute Myocardial Infarction (PRAMI) trial(1) released at the recent ESC meeting held in Amsterdam has attracted enormous interest and rightly so: if the conclusions drawn by the researchers prove correct, the management of patients presenting with a ST segment elevation myocardial infarction (STEMI) is about to undergo a major change. The authors provide evidence to support “preventive PCI” in non-infarct related coronary arteries in patients with multivessel disease undergoing angiography with the objective of opening the infarct related coronary artery. These findings challenge the long-held view, reflected in international guidelines, that PCI in this setting should be aimed only at the so-called culprit lesion. It also challenges the view that the likelihood of atheromatous plaque rupture is primarily related to the properties of the plaque (degree of inflammation, cap thickness, cholesterol content) and not the degree of stenosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
